Find the products and resources you are looking for!
Miltenyi Biotec distribution:
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
In the presentation we will discuss:
• how to successfully translate NK and T cell research workflows into clinical applications
• current challenges around manufacturing of gene-engineered NK and T cells and possible solutions
• optimization strategies for IPC and QC flow assays in the context of engineered cell products
Global Product Manager, Miltenyi Biotec
Melanie Rietenbach is Global Product Manager for the clinical engineered cells portfolio including CAR T and CAR NK cells at Miltenyi Biotec. During the past year, she has been working together with the R&D and Clinical Development Team in order to advance the development of tools to enable CAR T and CAR NK cell immunotherapy. Before that, Melanie already supported Miltenyi Biotec in her role as Application Development Specialist and Clinical Product Specialist for more
than three years. During that time, she was responsible for technical support and application training on Miltenyi Biotec’s clinical product portfolio with focus on cell and gene therapy applications and related products. Prior to joining Miltenyi Biotec, Melanie obtained her Ph.D. at the University of Erlangen-Nuremberg (DFG- fellowship) analyzing the role of autophagy in the cells of the immune system.Read more …
Only participants of the 18th CIMT Annual Meeting can access the seminar
through the event platform.
Copyright © 2021 Miltenyi Biotec and/or its affiliates. All rights reserved.